Znanstveni rad - Prikaz slučaja
Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia
Annals of Hematology, 94 (2015), 9; 1617-1619. https://doi.org/10.1007/s00277-015-2428-6

Lucijanić, Marko; Lasan-Trčić, Ružica; Kušec, Rajko; Pejša, Vlatko; Štoos-Veić, Tajana; Jakšić, Ozren

Citirajte ovaj rad

Lucijanić, M., Lasan Trčić, R., Kušec, R., Pejša, V., Štoos Veić, T. i Jakšić, O. (2015). Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology, 94. (9), 1617-1619. doi: 10.1007/s00277-015-2428-6

Lucijanić, Marko, et al. "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia." Annals of Hematology, vol. 94, br. 9, 2015, str. 1617-1619. https://doi.org/10.1007/s00277-015-2428-6

Lucijanić, Marko, Ružica Lasan Trčić, Rajko Kušec, Vlatko Pejša, Tajana Štoos Veić i Ozren Jakšić. "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia." Annals of Hematology 94, br. 9 (2015): 1617-1619. https://doi.org/10.1007/s00277-015-2428-6

Lucijanić, M., et al. (2015) 'Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia', Annals of Hematology, 94(9), str. 1617-1619. doi: 10.1007/s00277-015-2428-6

Lucijanić M, Lasan Trčić R, Kušec R, Pejša V, Štoos Veić T, Jakšić O. Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology [Internet]. 09.2015. [pristupljeno 25.07.2024.];94(9):1617-1619. doi: 10.1007/s00277-015-2428-6

M. Lucijanić, R. Lasan Trčić, R. Kušec, V. Pejša, T. Štoos Veić i O. Jakšić, "Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia", Annals of Hematology, vol. 94, br. 9, str. 1617-1619, Rujan 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:462231. [Citirano: 25.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.